• MSR200 The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis

    Dec 1, 2025, 00:00

  • EPH126 Higher Mortality for Generalized Pustular Psoriasis Compared With Plaque Psoriasis Highlights the Need for Improved Treatments: Insights From a Meta-Analysis

    Dec 1, 2025, 00:00

  • EE448 Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024

    Dec 1, 2025, 00:00

  • PCR11 A Systematic Review of Trends From Migraine Preference Studies

    Dec 1, 2025, 00:00

  • PCR163 Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions

    Dec 1, 2025, 00:00

  • HTA253 NICE Guidance, Not-So-NICE Realities: Resource Constraints in HTA

    Dec 1, 2025, 00:00

  • EPH101 Experience of Pediatric Dental Screening in Hungary and in National Minority Groups in Romania

    Dec 1, 2025, 00:00

  • HTA228 Market Access 2030: AI-Driven Dossier Transformation and Therapeutic Value Communication Across Global Health Systems

    Dec 1, 2025, 00:00

  • SA91 Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions

    Dec 1, 2025, 00:00

  • MSR94 Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level

    Dec 1, 2025, 00:00

  • PCR170 Patient and Societal Preferences for On-Demand Treatment in Hereditary Angioedema: Estimation of Utility Using a Discrete Choice Experiment

    Dec 1, 2025, 00:00

  • SA61 Leveraging AI for Evidence Synthesis: Assessing the Accuracy and Efficiency of AI-Supported Data Extraction and Reporting

    Dec 1, 2025, 00:00

  • CO121 External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)

    Dec 1, 2025, 00:00

  • PCR12 A Targeted Review of Caregiver Experiences of CAR-T Therapy in Ambulatory Settings

    Dec 1, 2025, 00:00

  • CO104 Evaluating the Effectiveness of FitterLife: A Community-Based Virtual Weight Management Program for Overweight Adults Without Diabetes or Hypertension in Singapore

    Dec 1, 2025, 00:00

  • RWD120 Making Health Data Trustees Sustainable: An Overview of Potential Business and Financing Models

    Dec 1, 2025, 00:00

  • P33 Associations Between Undernutrition and Healthcare Utilization and Costs in Community-Dwelling Adults: A Longitudinal Observational Study

    Dec 1, 2025, 00:00

  • MSR13 Accumulating Eviden When Publication Bias Persists

    Dec 1, 2025, 00:00

  • RWD138 Primary Expenditure Drivers and Future Challenges From Emerging Technologies in Brazilian Private Market Real-World Data Analysis From a Brazilian Employer-Sponsored, Self-Insured Health Plan

    Dec 1, 2025, 00:00

  • HSD88 Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews

    Dec 1, 2025, 00:00

  • EE584 Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis

    Dec 1, 2025, 00:00

  • EE433 Evaluating the Annual Cost of Progression in CD30+ Cutaneous T-cell Lymphomas Following 2L+ Systemic Treatment in Italy

    Dec 1, 2025, 00:00

  • CO127 Health Gains Associated With Homologous Recombination Deficiency Testing for Ovarian Cancer in South Korea: A Model-Based Analysis

    Dec 1, 2025, 00:00

  • CO222 Survival Outcomes in People Living With HIV Who Experienced Progressive Multifocal Leukoencephalopathy Compared to the General Population

    Dec 1, 2025, 00:00

  • SA7 Adjusting to Nonoverlapping Variables in the Unanchored Matching-Adjusted Indirect Comparisons of Survival Outcomes: Application of Monte Carlo Simulations

    Dec 1, 2025, 00:00

  • SA23 Correspondence Between Patients' and Neurologists' Satisfaction With Treatment in Patients With CIDP: Results From a Real-World International Survey

    Dec 1, 2025, 00:00

  • HTA157 From the Outside Looking in: Patient Advocacy Groups' and Healthcare Providers' Perspectives on Patient Engagement Strategies in the Israeli Health Technology Assessment Process

    Dec 1, 2025, 00:00

  • EE128 Clinical and Economic Burden Among Patients Requiring Long-Term Intermittent Catheter Use in England: A Real-World Retrospective Observational Cohort Study

    Dec 1, 2025, 00:00

  • PCR143 Investigating the Importance of EQ-5D Domains and Two Bolt-on Items: How Do the Preferences of People With Acute Leukemia Differ From the General Population?

    Dec 1, 2025, 00:00

  • EE93 Budget Impact Analysis of Ondansetron Oral Dissolving Film vs. Oral Solution in the Chemotherapy-Induced Nausea and Vomiting for Egyptian Pediatric Patients

    Dec 1, 2025, 00:00

  • MSR16 Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models

    Dec 1, 2025, 00:00

  • EE609 Piloting Structured Expert Elicitation: An Exploratory Case Study of Practical Implementation

    Dec 1, 2025, 00:00

  • MT6 Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework

    Dec 1, 2025, 00:00

  • CO196 Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma

    Dec 1, 2025, 00:00

  • HPR59 Divergent Biologic Price Archetypes: Year-on-Year List Price Evolution Pre- and Post-Biosimilar Entry in the US, Europe, and Japan

    Dec 1, 2025, 00:00

  • CO180 Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review

    Dec 1, 2025, 00:00

  • EPH228 The Association Between Schizophrenia and Cardiovascular Diseases: A Retrospective Cohort Study in German Primary Care

    Dec 1, 2025, 00:00

  • SA73 Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US

    Dec 1, 2025, 00:00

  • CO239 The Effect of Nutritional Supplements on Semen Quality and Pregnancy Rates in Patients With Male Factor Infertility: A Systematic Literature Review and Network Meta-Analysis

    Dec 1, 2025, 00:00

  • EE457 Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer's Diagnostic Cost-Effectiveness Model

    Dec 1, 2025, 00:00

  • EE326 Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes

    Dec 1, 2025, 00:00

  • CO249 The Value of Persistence in Neovascular Age-Related Macular Degeneration

    Dec 1, 2025, 00:00

  • HPR21 An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and Implications of Differences in Cost of Living on Global Drug Pricing Policies

    Dec 1, 2025, 00:00

  • HPR183 Shortage of Antineoplastics and Supportive Medicines in Armenia

    Dec 1, 2025, 00:00

  • CO174 Overall Survival With Second-Generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review

    Dec 1, 2025, 00:00

  • PCR181 Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study

    Dec 1, 2025, 00:00

  • SA19 Characterizing Exploratory Endpoints in Early Oncology Trials: Insights From Trial Registry Audit

    Dec 1, 2025, 00:00

  • EE9 A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis

    Dec 1, 2025, 00:00

  • HTA137 Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals

    Dec 1, 2025, 00:00

  • HTA196 Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region

    Dec 1, 2025, 00:00

  • MT33 Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements

    Dec 1, 2025, 00:00

  • EE36 A Systematic Review of Using Social Return on Investments Within Healthcare Service Evaluations: Methodological Opportunity and Challenges

    Dec 1, 2025, 00:00

  • EE662 Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan

    Dec 1, 2025, 00:00

  • MSR67 Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?

    Dec 1, 2025, 00:00

  • HTA61 Budget Impact Models in CEESP Opinions: A Decade of Insights

    Dec 1, 2025, 00:00

  • HSD70 Mapping Anatomic Pathology Laboratories of Public Hospitals in Gree Units, Infrastructure, Personnel, and Workload Estimation

    Dec 1, 2025, 00:00

  • EPH184 Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization

    Dec 1, 2025, 00:00

  • EE58 Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France

    Dec 1, 2025, 00:00

  • EE69 Assessment of the Economic and Societal Impact of Cervical Cancer Treatment in Bulgaria

    Dec 1, 2025, 00:00

  • SA63 Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients

    Dec 1, 2025, 00:00

  • PCR80 Evaluating Migration Errors in COA: Development and Validation of the IQVIA Migration Error Severity Scale (I-MESS)

    Dec 1, 2025, 00:00

  • HTA202 Insights and Implications an Analysis of the Studies Undertaken by HTAIn (Health Technology Assessment in India)

    Dec 1, 2025, 00:00

  • HTA262 Overall Survival Adjusted for Subsequent Treatments: A Review of Health Technology Assessments

    Dec 1, 2025, 00:00

  • EPH160 Measurement of Functional Outcome Using the Modified Rankin Scale in Patients With Acute Ischemic Stroke

    Dec 1, 2025, 00:00

  • RWD142 Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market

    Dec 1, 2025, 00:00

  • EE7 A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization

    Dec 1, 2025, 00:00

  • EE94 Budget Impact Analysis of Rozanolixizumab for the Treatment of Generalized Myasthenia Gravis (gMG) in Greece

    Dec 1, 2025, 00:00

  • CO22 Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit

    Dec 1, 2025, 00:00

  • EE702 The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE277 Cost-Effectiveness of Strategies to Prevent Respiratory Syncytial Virus Infections Among Infants in Ireland

    Dec 1, 2025, 00:00

  • HPR87 Extension of the Mammographic Screening Program in Italy: Cost-Benefit Analysis and Impact of Early Diagnosis in the 45-74 Age Group

    Dec 1, 2025, 00:00

  • HTA183 HTA and Regulatory Perspectives on Robustness of Evidence and Management of Uncertainties

    Dec 1, 2025, 00:00

  • HSD29 CREST Physician Experience Survey: Evaluating the Impact of Time and Effort of Treatment Administration in Non-Muscle Invasive Bladder Cancer (NMIBC)

    Dec 1, 2025, 00:00

  • EPH144 Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data

    Dec 1, 2025, 00:00

  • RWD118 Leveraging Large-Language Models for Medical Code List Creation: An Example Using the Charlson Comorbidity Index

    Dec 1, 2025, 00:00

  • HTA73 Challenges in the German AMNOG Procedure: The Need for National PICO Transparency and Optimized Consultation Windows in the Context of EU-HTA

    Dec 1, 2025, 00:00

  • HTA130 Evaluating Clinical Similarity: A Systematic Review of Methods Used Within National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) When Relying on Statistically Nonsignificant Differences From Indi ...

    Dec 1, 2025, 00:00

  • EE290 Costs Associated With the Treatment of Surgical Site Infections in Solid Organ Transplant Recipients: A Scoping Review

    Dec 1, 2025, 00:00

  • HTA326 The Phantom Mena How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access

    Dec 1, 2025, 00:00

  • EE496 Healthcare and Economic Burden of Intravenous and Subcutaneous Immunoglobulin Treatment in Three Autoimmune Neuromuscular Diseases: A Bicentric Spanish Experience

    Dec 1, 2025, 00:00

  • EE120 Can Intravitreal Aflibercept 8 mg Result in Decreased Treatment Burden and Treatment Costs in European Patients With Age-Related Macular Degeneration? Early Evidence From Clinical Practice

    Dec 1, 2025, 00:00

  • EE628 Quantifying the Fiscal Value of Prevention Programs for Depression

    Dec 1, 2025, 00:00

  • PCR82 Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling

    Dec 1, 2025, 00:00

  • MSR2 A Disease Progression Model Comparing Respiratory and Motor Decline in People With Late-Onset Pompe Disease Treated With Cipaglucosidase Alfa Plus Miglustat vs. Alglucosidase Alfa

    Dec 1, 2025, 00:00

  • EE425 Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma

    Dec 1, 2025, 00:00

  • PCR222 Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods

    Dec 1, 2025, 00:00

  • EE92 Budget Impact Analysis of Obecabtagene Autoleucel for Adults With Relapsed/Refractory B-cell ALL From a US Payer Perspective

    Dec 1, 2025, 00:00

  • CO240 The Impact of Dietary Supplements (Vitamin B12, Vitamin D, Magnesium) on the Quality of Life (QoL) of Users in Edessa, Northern Greece

    Dec 1, 2025, 00:00

  • EE620 Projected Public Health Impact of Synchronized COVID-19 and Influenza Vaccination With a Combination Vaccine in US Older Adults

    Dec 1, 2025, 00:00

  • SA13 Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review

    Dec 1, 2025, 00:00

  • EPH166 Mortality in COPD and Cardiovascular Disease Comorbidity: Survival Analysis Using Curated Data From Brazilian Public Healthcare System (SUS)

    Dec 1, 2025, 00:00

  • HTA7 A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA

    Dec 1, 2025, 00:00

  • EE420 Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States

    Dec 1, 2025, 00:00

  • EPH190 Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences

    Dec 1, 2025, 00:00

  • PCR242 The Road Ahead: A Qualitative Study Mapping the Experience of Patients With Chronic Kidney Disease

    Dec 1, 2025, 00:00

  • HPR184 Single-Arm Trials and Reimbursement Decision Making in Europe: A Case Study in Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • EE324 Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • PCR161 Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS

    Dec 1, 2025, 00:00

  • HTA254 NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance?

    Dec 1, 2025, 00:00

  • CO203 Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE47 An Economic Evaluation to Inform the Use of Enhanced Influenza Vaccines for Those Aged 65 Years and Older in the Seasonal Influenza Vaccination Program in Ireland

    Dec 1, 2025, 00:00

  • HPR37 Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France

    Dec 1, 2025, 00:00

  • P49 Social and Economic Burden Among Patients With Inherited Retinal Disease: A Nationwide Matched Cohort Study in Sweden 2001-2021

    Dec 1, 2025, 00:00

  • EE291 Costs of Breast Cancer Surgical Care in Newly Diagnosed Patients in 2015 and 2019: A French Nationwide Claims Database Study

    Dec 1, 2025, 00:00

  • RWD47 DARAH Project: Deploying a Datashield Federated Network in Real-World Healthcare Environments

    Dec 1, 2025, 00:00

  • EE753 What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?

    Dec 1, 2025, 00:00

  • EE2 A Budget Impact Analysis of Exclusive Human Milk Diet in Very Low Birth Weight Infants in Sheikh Shakhbout Medical City

    Dec 1, 2025, 00:00

  • CO161 Management of Biliary Tract Cancer: A Modified Delphi (Consensus) Survey of UK Clinical Experts

    Dec 1, 2025, 00:00

  • MSR28 Anchors Away: Navigating Unanchored Indirect Comparisons With Multilevel Unanchored Meta-Regression (ML-UMR)

    Dec 1, 2025, 00:00

  • HPR68 Eligibility and Strategic Implications of Germany’s 2025 Confidential Pricing Reform

    Dec 1, 2025, 00:00

  • CO43 Clinical Burden and Transfusion-Related Outcomes in Transfusion-Dependent Thalassemia in the Kingdom of Saudi Arabia and United Arab Emirates

    Dec 1, 2025, 00:00

  • HTA264 Patient Access Delays for Subsequent High-Value Indications of Multi-Indication Treatments: An Assessment of Health Technology Assessment Decision Making

    Dec 1, 2025, 00:00

  • RWD26 Burden of Duchenne Muscular Dystrophy in Italy: A Multicenter Cost of Illness Study

    Dec 1, 2025, 00:00

  • EPH64 Disease Progression in Adults With Hepatitis Delta Virus vs. Hepatitis B Virus Monoinfection in Inpatient and Outpatient Settings in Italy

    Dec 1, 2025, 00:00

  • PCR239 The Rapid Involvement of Patients and the Public in Evidence Synthesis (RIPPLES) Framework: Development and Guidance

    Dec 1, 2025, 00:00

  • EE666 Socioeconomic Burden (SOB) of Multiple Sclerosis (MS) in Latin America (LATAM): Trends and Projections 2017-2032

    Dec 1, 2025, 00:00

  • HPR151 Optimizing Healthcare Systems in the MENA Region: Insights From Tailored Reimbursement for Innovative and Generic Essential Remedies (TRIGER) Meetings in Saudi Arabia and Algeria

    Dec 1, 2025, 00:00

  • EE752 What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024

    Dec 1, 2025, 00:00

  • EE485 HDX vs. HDF in End-Stage Kidney Disease: Cost-Minimization Study in Saudi Arabia

    Dec 1, 2025, 00:00

  • RWD63 Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data

    Dec 1, 2025, 00:00

  • CO165 Modeling Intelligence Quotient (IQ) Changes Relative to Blood Phe Levels in Individuals With Phenylketonuria (PKU) Treated With Sepiapterin and Sapropterin Dihydrochloride

    Dec 1, 2025, 00:00

  • MSR97 Evaluating the Use of Large Language Models (LLM) in Summarizing Treatment Guidelines: A Pilot Study

    Dec 1, 2025, 00:00

  • EPH231 The Cost of Complacency: Projecting the Burden of HIV Care in Eight European Countries

    Dec 1, 2025, 00:00

  • MSR182 Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk

    Dec 1, 2025, 00:00

  • EE155 Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal

    Dec 1, 2025, 00:00

  • CO50 Clinical Profile of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated With Complement Inhibitors: Results From a Real-World Study

    Dec 1, 2025, 00:00

  • EPH131 Identifying CKD As a Key Driver of CVD Deaths

    Dec 1, 2025, 00:00

  • EE686 The Broader Economics of Chronic Spontaneous Urticaria (CSU) in Japan: Assessing Societal and Fiscal Benefits of Novel Therapies

    Dec 1, 2025, 00:00

  • EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)

    Dec 1, 2025, 00:00

  • EE331 Direct and Indirect Economic Burden Due to Chronic Limb-Threatening Ischemia (CLTI) in Germany

    Dec 1, 2025, 00:00

  • EPH18 Are Anti-Obesity Drugs Life-Saving or Lifestyle Medicines? Reframing the Policy and Economic Debate

    Dec 1, 2025, 00:00

  • HPR130 Investigation of Patient Satisfaction With Home Nursing Care Among Recipients

    Dec 1, 2025, 00:00

  • EPH137 Impact of the Decline in the Number of Community Dermatologists in France on Treatment of Actinic Keratosis (EPIKA Study)

    Dec 1, 2025, 00:00

  • EE719 The Overlooked Need for Modeling Beyond Reimbursement to Support Therapy Uptake: Case Study of Botulinum Toxin for Spasticity Treatment

    Dec 1, 2025, 00:00

  • EPH182 Population-Level Impact of T-DM1 Use for HER2-Positive Early Breast Cancer According to National Clinical Practice Guidelines in Sweden

    Dec 1, 2025, 00:00

  • HTA168 Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment

    Dec 1, 2025, 00:00

  • PCR119 Health-Related Quality of Life in Patients With Mild Cognitive Impairment and Dementia and Their Caregivers in Thailand: A Cross-Sectional Study

    Dec 1, 2025, 00:00

  • HPR6 A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024

    Dec 1, 2025, 00:00

  • EPH143 Incidence of Neutropenia Adverse Events Identified in Electronic Healthcare Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK

    Dec 1, 2025, 00:00

  • RWD18 Archival Sample Testing for Real-World Insights: Innovative Approaches to Enriching Retrospective Studies With Biomarker Data

    Dec 1, 2025, 00:00

  • HTA46 Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)

    Dec 1, 2025, 00:00

  • HTA244 Navigating HTA Requirements: The Current Landscape of Alzheimer's Disease-Modifying Treatments

    Dec 1, 2025, 00:00

  • EE680 System-Level Economic Impact of a Combination Influenza-COVID-19 Vaccine vs. Standalone Vaccinations in the United Kingdom

    Dec 1, 2025, 00:00

  • PCR19 Are We Measuring What Matters in Postpartum Depression Trials?

    Dec 1, 2025, 00:00

  • EE174 Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination

    Dec 1, 2025, 00:00

  • EE539 Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)

    Dec 1, 2025, 00:00

  • HTA148 Fractional Polynomial Survival Models in HTA: An Exploratory Review of Use and Methodological Guidance Across Global Agencies

    Dec 1, 2025, 00:00

  • EPH97 Evolution and Geographical Patterns of the Portuguese Newborn Screening Program in the Last 10 Years

    Dec 1, 2025, 00:00

  • HTA225 LLM Engineering in HEOR: Approaches to Improving Accuracy in Clinical Data Extraction

    Dec 1, 2025, 00:00

  • PCR114 Health-Related Quality of Life Following Administration of Influenza and COVID-19 Combination Vaccine in Older Adults: Results From a Phase 3 Randomized Controlled Trial

    Dec 1, 2025, 00:00

  • MT24 Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)

    Dec 1, 2025, 00:00

  • SA24 Cost Variation Across Lung-Cancer Diagnostic-Pathway Clusters: A Nationwide Real-World Analysis of 18,569 French Patients

    Dec 1, 2025, 00:00

  • EE751 What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses

    Dec 1, 2025, 00:00

  • EPH22 Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations

    Dec 1, 2025, 00:00

  • EPH73 Epidemiological Analysis of Colorectal Cancer in Cyprus Amidst the Absence of Organized Screening Programs Data From 2000 to 2020

    Dec 1, 2025, 00:00

  • OP24 Turning SAP Feedback into HTA-Ready Action: A Semi-Automated Approach for RWD Studies

    Dec 1, 2025, 00:00

  • HSD18 Burden of In-Clinic and At-Home Administration of Injectable Biologics for Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Interim Results From a Time and Motion Study

    Dec 1, 2025, 00:00

  • SA8 AI for Rapid Data Extraction: A Case Study on the Economic and Caregiver Burden of Motor Neuron Disease

    Dec 1, 2025, 00:00

  • EPH13 An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Rheumatoid Arthritis Using the THIN Dataset

    Dec 1, 2025, 00:00

  • EE77 Bridging the Gap: Why Cost-Effectiveness Analyses of Congenital Heart Interventions Are Critical for Person-Centered Value-Based Care

    Dec 1, 2025, 00:00

  • HSD75 Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in Fran EPIKA Study

    Dec 1, 2025, 00:00

  • MSR76 Diagnostic Patterns and Subtype Overlap in Idiopathic Inflammatory Myopathies: A Retrospective Claims-Based Cohort Study

    Dec 1, 2025, 00:00

  • PT27 Synthetic Data Generation vs. Simulated Treatment Comparison: Assessment of the Performance of a Novel Approach for Unanchored Indirect Treatment Comparisons

    Dec 1, 2025, 00:00

  • EE633 Real-World Cost of Automated Red Blood Cell Exchange for Sickle Cell Disease in Kenya: A Cost-Reimbursement Gap Analysis From a Public Sector Perspective

    Dec 1, 2025, 00:00

  • HTA175 Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective

    Dec 1, 2025, 00:00

  • HPR124 Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework

    Dec 1, 2025, 00:00

  • MT27 Impact of Companion Diagnostics (CDx) on Reimbursement Outcomes of Breast Cancer and NSCLC Therapies

    Dec 1, 2025, 00:00

  • HTA79 Comparative Clinical Effectiveness in Skin Cancer: Lessons From HTA Decision Making in EU4, UK, and Australia

    Dec 1, 2025, 00:00

  • PCR214 Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries

    Dec 1, 2025, 00:00

  • HSD68 Lean Assessment Process Methodology for RMD-Health: Evaluating Clinical Need Usefulness Adoption Barriers and Early Economic Value of AI in NHS Rheumatology Referrals

    Dec 1, 2025, 00:00

  • HSD58 How Do Neurologists Perceive the Organization and Functioning of Care in Their Multiple Sclerosis Units?

    Dec 1, 2025, 00:00

  • HTA126 Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?

    Dec 1, 2025, 00:00

  • EE325 Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA

    Dec 1, 2025, 00:00

  • HPR117 Impact of the COVID-19 Pandemic on Healthcare Expenditure

    Dec 1, 2025, 00:00

  • HTA203 Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5

    Dec 1, 2025, 00:00

  • RWD148 Real-World Associations Between Smoking Status and Genetic Driver Mutations in Metastatic Lung Cancer in US Community Oncology

    Dec 1, 2025, 00:00

  • EE29 A Real-World Study of Healthcare Resource Utilization (HCRU) and Associated Healthcare Costs for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) in Taiwan

    Dec 1, 2025, 00:00

  • SA16 Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies

    Dec 1, 2025, 00:00

  • P44 Early Economic Modeling to Estimate Cost-Effectiveness and Value-Based Price of a Gene Therapy for Urofacial Syndrome

    Dec 1, 2025, 00:00

  • CO57 Comparative Efficacy of First-Line (1L) Therapies for Patients With Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (mCRPC): An Updated Systematic Literature Review (SLR) and Bayesian Network Meta-Analys ...

    Dec 1, 2025, 00:00

  • EE365 Economic Burden of Schizophrenia: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR260 Utility Estimates for Health States Associated With Immune Thrombocytopenia: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • Measuring the First Mover Advantage in US Biosimilar Markets

    Dec 1, 2025, 00:00

  • HSD107 The Evolving Role of Pharmacists as Vaccinators in New Zealand and Denmark

    Dec 1, 2025, 00:00

  • EE299 Cost-Utility Analysis of AI-Assisted Ultrasound for Breast Cancer Detection in Taiwan

    Dec 1, 2025, 00:00

  • SA9 AI in Pragmatic Literature Reviews: A Scoping Review of Current Guidance and Development of a Framework for Integration

    Dec 1, 2025, 00:00

  • PCR103 Generalizability of Patient Preference Study Results: A Weight and Test Approach

    Dec 1, 2025, 00:00

  • MT43 Unlocking Value Early: Insights Into NICE’s Early Value Assessments and Evidence-Generation Plans for Medical Technologies

    Dec 1, 2025, 00:00

  • RWD101 Improving Data Quality in Oncology Electronic Health Record (EHR)-Derived Databases for Research and Regulatory Decision Making

    Dec 1, 2025, 00:00

  • EPH271 Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast

    Dec 1, 2025, 00:00

  • HTA38 Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?

    Dec 1, 2025, 00:00

  • EPH50 Comparative Epidemiological Burden of Osteoarthritis in Eastern Central and Western Europe Based on the Global Burden of Disease Study 2021

    Dec 1, 2025, 00:00

  • PCR90 Exploring Beyond the Gut: A Qualitative Study of Extraintestinal Symptoms in Ulcerative Colitis and Crohn's Disease

    Dec 1, 2025, 00:00

  • EE372 Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain

    Dec 1, 2025, 00:00

  • HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update

    Dec 1, 2025, 00:00

  • PCR51 Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey

    Dec 1, 2025, 00:00

  • HPR101 From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025

    Dec 1, 2025, 00:00

  • CO133 Identifying Dogs to Be Screened for Canine Chronic Kidney Disease (cCKD)

    Dec 1, 2025, 00:00

  • EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom

    Dec 1, 2025, 00:00

  • EE436 Evaluating the Cost-Effectiveness of Adjuvanted Influenza Vaccine in the Older Adult Population in the Netherlands

    Dec 1, 2025, 00:00

  • OP7 Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic

    Dec 1, 2025, 00:00

  • RWD75 Epidemiology of Pulmonary Arterial Hypertension In Fran A Real-World Study Using the French National Healthcare Database (SNDS)

    Dec 1, 2025, 00:00

  • CO48 Clinical Outcomes Associated With Pembrolizumab Immunotherapy in Mesothelioma: A Systematic Review

    Dec 1, 2025, 00:00

  • EE236 Cost-Effectiveness of Artificial Intelligence Interventions for Musculoskeletal Disorders: Systematic Review

    Dec 1, 2025, 00:00

  • RWD56 Descriptive Comparison of Patient Characteristics and Treatment Patterns in Metastatic NSCLC: US and France Cohorts to Inform Transportability

    Dec 1, 2025, 00:00

  • MT25 Hope and Acceptance of AI-Guided Psychotherapy: Patient Adoption of Conversational AI in Mental Health Care

    Dec 1, 2025, 00:00

  • HPR120 Implications of Recent US Policy Changes on Evidence Generation Requirements for Enabling Access to Medicines and Vaccines in Low- and Middle-Income Countries

    Dec 1, 2025, 00:00

  • CO47 Clinical Expert Opinion on the Impact of Vosoritide on Health and Function in Children With Achondroplasia

    Dec 1, 2025, 00:00

  • HTA338 Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)

    Dec 1, 2025, 00:00

  • PCR219 Socioeconomic Burden of Pulmonary Arterial Hypertension on Patients and Caregivers in the Czech Republic

    Dec 1, 2025, 00:00

  • HTA349 Use of AI Methods in NICE Technology Appraisals: What Is the Current Status Quo?

    Dec 1, 2025, 00:00

  • EE32 A Systematic Literature Review of Cost of Illness Studies on Atrial Fibrillation With Focus on the Methodologies Economic Burden and Factors Influencing the Cost of Atrial Fibrillation Among European and North American Countries

    Dec 1, 2025, 00:00

  • HPR182 Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?

    Dec 1, 2025, 00:00

  • EPH155 KRAS Alterations in Advanced Non-Small Cell Lung Cancer (NSCLC): Temporal Trends in Testing Patterns and Targeted Treatment Use Across Europe Between 2018 and 2024

    Dec 1, 2025, 00:00

  • EE559 Intra-Procedure Cost Variability: A Retrospective Analysis of Real-World Patient Level Information Costing (PLICS) Data for a Minimally Invasive BPO Therapy in the NHS

    Dec 1, 2025, 00:00

  • MSR197 The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses

    Dec 1, 2025, 00:00

  • EE371 Economic Evaluation in the MENA Region (2015-2025): A Targeted Review of Methodological Rigor and Policy Relevance

    Dec 1, 2025, 00:00

  • EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada

    Dec 1, 2025, 00:00

  • PCR15 An Initiative to Improve Patient Organization Engagement at the National Center for Pharmacoeconomics, Ireland

    Dec 1, 2025, 00:00

  • HPR38 Bridging the Gap: What Spain Can Learn From European Leaders in Digital Therapy Reimbursement

    Dec 1, 2025, 00:00

  • EPH61 Development of an Indicator-Based Framework for Epidemic Phase Classification in Emerging Respiratory Infectious Diseases

    Dec 1, 2025, 00:00

  • HSD34 Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States

    Dec 1, 2025, 00:00

  • EPH6 A Real-World Study on Italian Administrative Healthcare Data to Describe Patients With Chronic Obstructive Pulmonary Disease by Therapeutic Pattern and Exacerbation Rate

    Dec 1, 2025, 00:00

  • HSD42 Effectiveness of Community Health Worker vs. Professional Care in Obesity Management: Preliminary Findings From a SMART Trial

    Dec 1, 2025, 00:00

  • HTA274 Pricing Analysis of Value-Added Medicines (VAMs) in Europe: A Call for Recognition of Patient-Centric Innovation

    Dec 1, 2025, 00:00

  • HTA245 Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers

    Dec 1, 2025, 00:00

  • PCR195 Psychometric Evaluation of the Impact of Weight on Quality of Life–Lite Clinical Trials (IWQOL-Lite-CT) Version in Adults Participating in a Pharmacological Clinical Trial for Obesity

    Dec 1, 2025, 00:00

  • HSD77 Number of Inquiries for a Second Course of Teprotumumab in the US Over Four Years

    Dec 1, 2025, 00:00

  • EE6 A Comparison of Treatment Costs for CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative HR+/HER2-: Early Breast Cancer (EBC) in Sweden

    Dec 1, 2025, 00:00

  • EE144 Comparison of the Environmental Impact of Subcutaneous vs. Oral Therapies

    Dec 1, 2025, 00:00

  • HPR176 Review and Horizon Scanning of Advanced Therapy Medicinal Products in Slovenia: Registration, Reimbursement, and Future Pipeline

    Dec 1, 2025, 00:00

  • HTA122 Effectiveness and Safety of Radiofrequency Nucleolysis for Chronic or Acute Low Back Pain

    Dec 1, 2025, 00:00

  • EE397 Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico

    Dec 1, 2025, 00:00

  • PCR14 Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs

    Dec 1, 2025, 00:00

  • HPR35 Benefits and Challenges in the Implementation of EU HTAR for Medical Devices: Lessons Learned From the Pharmaceutical Industry

    Dec 1, 2025, 00:00

  • EE193 Cost-Consequence of Incorporating Single-Operator Direct Visualization Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures in Saudi Arabia

    Dec 1, 2025, 00:00

  • EPH65 Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis

    Dec 1, 2025, 00:00

  • MT34 Patient Acceptance of Health Information Technologies: Comparative Insights From Wearables, TelE-Medicine, and mHealth

    Dec 1, 2025, 00:00

  • SA5 A Systematic Literature Review on Economic Evaluations and Cost-Effectiveness of Second-Line Treatment Options for Immune Thrombocytopenia

    Dec 1, 2025, 00:00

  • EPH15 Analysis of Factors Behind Differences Between Official Drug Pricing and Cost-Effectiveness Evaluation in Japan and Policy Implications

    Dec 1, 2025, 00:00

  • RWD173 Short- and Longer-Term Healthcare Resource Utilization and Related Costs With Psoriasis in Brazilian Private Market

    Dec 1, 2025, 00:00

  • HTA89 CONITEC in Action: A Trend Analysis of CONITEC’s Evaluation Outcomes From 2020 to Present Day

    Dec 1, 2025, 00:00

  • CO167 Multimorbidity and Health-Related Quality of Life Among Adult Population in the United States

    Dec 1, 2025, 00:00

  • CO251 Time to and Time in Better Health States With Sotatercept for Pulmonary Arterial Hypertension: A Modeling Study

    Dec 1, 2025, 00:00

  • EE627 Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective

    Dec 1, 2025, 00:00

  • EE646 Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib

    Dec 1, 2025, 00:00

  • HSD122 Utilization of Informal WhatsApp for Pre- and Postnatal Referral Services in the Kwadaso Municipality of Ghana

    Dec 1, 2025, 00:00

  • EE228 Cost-Effectiveness Assessment of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among At-Risk and High-Risk Adults in India

    Dec 1, 2025, 00:00

  • EPH128 Hospital Systemic Treatment for HepatoCarcinoma: The HOSTHECA Study

    Dec 1, 2025, 00:00

  • HSD80 Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis

    Dec 1, 2025, 00:00

  • HTA146 Exploring Nordic Real-World Evidence Sources for a PICO Assessment of a Hypothetical Oncology Drug and Medical Device Product

    Dec 1, 2025, 00:00

  • MSR101 Excel Front-End, R Back-End: A Gateway to Faster Individual Patient Simulations and Probabilistic Sensitivity Analyses in Cost-Effectiveness Models for HTA

    Dec 1, 2025, 00:00

  • MT35 Potential Impacts of Improvement in Turnaround Time

    Dec 1, 2025, 00:00

  • HPR62 Do Patient-Reported Outcomes Influence Drug Prices? Evidence From the Italian Pricing and Reimbursement System

    Dec 1, 2025, 00:00

  • P30 Assessment of Mortality and COPD Exacerbations in GOLD E COPD Patients in the Netherlands

    Dec 1, 2025, 00:00

  • MSR62 Cost of Illness Studies Published Between 2010 and 2023 in Türkiye

    Dec 1, 2025, 00:00

  • CO54 Comparative Efficacy and Safety of Avacincaptad Pegol vs. Pegcetacoplan in Treatment of Geographic Atrophy: Insights From a Multilevel Network Meta-Regression

    Dec 1, 2025, 00:00

  • PCR50 Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review

    Dec 1, 2025, 00:00

  • EE746 Utilization and Patient Characteristics of Robotic-Assisted Colorectal Surgery in Germany: A Claims Data Analysis

    Dec 1, 2025, 00:00

  • SA58 Investigating Functional Status and Healthcare Resource Utilization of Patients With Cognitive Impairment Associated With Schizophrenia: Findings From a Real-World Noninterventional Study

    Dec 1, 2025, 00:00

  • HPR167 Publicly Funded Fertility Preservation Services for Medical Reasons in Selected Countries

    Dec 1, 2025, 00:00

  • EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States

    Dec 1, 2025, 00:00

  • HTA187 HTA Life-Cycle Concepts: The Need for HTA Bodies to Grow Beyond Their Traditional Scope

    Dec 1, 2025, 00:00

  • CO24 Balancing Innovation and Propriety: The Question of Copyright Holder’s Opinions on GenAI Usage While Localizing Their Intellectual Property

    Dec 1, 2025, 00:00

  • CO230 Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy

    Dec 1, 2025, 00:00

  • HTA182 How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?

    Dec 1, 2025, 00:00

  • P20 The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia

    Dec 1, 2025, 00:00

  • MSR127 Implementing Simultaneous Maximum Acceptable Risk Thresholds (SMARTs) in Discrete Choice Experiments (DCE): A Feasible Approach to Quantify Tolerance for Multiple Risks

    Dec 1, 2025, 00:00

  • EE52 Analysis of the Fiscal and Socioeconomic Impact of a National Social Program to Support In Vitro Fertilization in Romania: A Generational Accounting Model

    Dec 1, 2025, 00:00

  • EE532 Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Antimicrobial Resistant Infections and Antibiotic Prescriptions in Greece

    Dec 1, 2025, 00:00

  • RWD98 Hospital Burden of Pulmonary Arterial Hypertension in Fran A Real-World Study Using the French Hospitalization Database (PMSI)

    Dec 1, 2025, 00:00

  • HTA197 Importance of Decisional Context in the Health Technology Assessment (HTA) of Advanced Therapy Medicinal Products (ATMPs)

    Dec 1, 2025, 00:00

  • EE455 Exploratory Assessment of the Societal Impact of Changing Informal Care Hours in the Netherlands

    Dec 1, 2025, 00:00

  • HPR92 Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database

    Dec 1, 2025, 00:00

  • PCR45 Cognitive Debrief of the PROMIS Parent Proxy Mobility Item Bank in Caregivers of Children Living With Duchenne Muscular Dystrophy

    Dec 1, 2025, 00:00

  • EE622 Proportion of the Expenses of Over-the-Counter Equivalent Drugs Among Total Healthcare an Analysis Using the Wellness-Star∗ Database

    Dec 1, 2025, 00:00

  • CO246 The Prevalence of COAs and DHTs for Studying Sleep Disorders in Clinical Trials

    Dec 1, 2025, 00:00

  • EE295 Cost-Utility Analysis (CUA) of Sepiapterin for Treatment of Phenylketonuria (PKU)

    Dec 1, 2025, 00:00

  • EE159 Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland

    Dec 1, 2025, 00:00

  • EE535 Impact of Indirect Treatment Comparison (ITC) Methodology on Cost-Effectiveness of Quizartinib in Acute Myeloid Leukemia (AML) in Canada and the United Kingdom (UK)

    Dec 1, 2025, 00:00

  • HTA13 A Review of Cost Comparisons Submitted to NICE Since the Introduction of the Proportional Approach to Technology Appraisal

    Dec 1, 2025, 00:00

  • EE181 Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • EE726 The Socioeconomic Value of Adult Respiratory Immunization Programs in Fran Can Improved Coverage Unlock Missed Gains?

    Dec 1, 2025, 00:00

  • HSD116 Treatment Patterns, Inadequate Disease Control, and Burden/Unmet Need Among Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Adelphi Real-World Disease Specific Program

    Dec 1, 2025, 00:00

  • PCR258 Use of EORTC Item Lists for Patient-Reported Outcome Measurement in Industry-Sponsored Research: A Three-Year Snapshot of Study Characteristics

    Dec 1, 2025, 00:00

  • HTA335 The Use of Real-World Evidence in Health Technology Assessment and the Application of the NICE RWE Framework: A Review of NICE Technology Appraisals

    Dec 1, 2025, 00:00

  • HTA87 Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease

    Dec 1, 2025, 00:00

  • HTA55 Beyond the QALY: An Analysis of Uncaptured Benefits in NICE Oncology Technology Appraisals 2023-2025

    Dec 1, 2025, 00:00

  • EE581 Mobile Diagnostic Services for Stationary Care in Germany: An Economic Evaluation Model for the DIKOM Project (01NVF21101)

    Dec 1, 2025, 00:00

  • EPH77 Epidemiological Trends in HPV-Related Cancers and Diseases in the United Kingdom

    Dec 1, 2025, 00:00

  • EPH140 Incidence and Prevalence of Primary Biliary Cholangitis (PBC) and Cholestatic Pruritus (CP) in Germany: Results From a Statutory Health Insurance (SHI) Claims Analysis

    Dec 1, 2025, 00:00

  • P59 Challenges in Assessing Trade-offs Between Efficiency and Equity in the Use of Digital Health Applications for Stroke Care

    Dec 1, 2025, 00:00

  • CO118 Exploring Synergistic ADC-ICI Combinations in Breast Cancer: Clinical Insights From a Scoping Review

    Dec 1, 2025, 00:00

  • HTA232 Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia

    Dec 1, 2025, 00:00

  • EE1 Care Now, Pay Later (CNPL): Evaluating the Budgetary and Access Implications of a Novel Financing Model for Inclisiran in Atherosclerotic Cardiovascular Disease (ASCVD) Patients in India

    Dec 1, 2025, 00:00

  • MSR89 Evaluating a Deep Learning Model for Classifying Pediatric Pneumonia in Israel

    Dec 1, 2025, 00:00

  • RWD97 Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis

    Dec 1, 2025, 00:00

  • EE729 The Working Dead? Why Longer Lives Can Seem Less Productive

    Dec 1, 2025, 00:00

  • EE483 Has the IRA Impacted International Price Differentials? Comparing US and German Drug Prices in the Era of MFP

    Dec 1, 2025, 00:00

  • CO64 Correlation Between Extension Survival Benefits and Incremental Costs of Oncology Drugs in Portugal: A Cross-Sectional, Regression Analysis

    Dec 1, 2025, 00:00

  • MSR213 Use of Multilevel Network Meta Regression (ML-NMR) Model in RET Mutation-Positive Medullary Thyroid Cancer (MTC)

    Dec 1, 2025, 00:00

  • HTA163 Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries

    Dec 1, 2025, 00:00

  • PCR33 Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies

    Dec 1, 2025, 00:00

  • EPH86 Estimating the Age- and Sex-Standardized Prevalence and Incidence of Depression and Anxiety in UK Adults Using the THIN Database

    Dec 1, 2025, 00:00

  • EE374 Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan

    Dec 1, 2025, 00:00

  • HPR165 Price-Volume Regulation in Fran Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations

    Dec 1, 2025, 00:00

  • CO225 Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of the First-Line (1L) Treatments of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Dec 1, 2025, 00:00

  • HSD19 Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)

    Dec 1, 2025, 00:00

  • CO10 Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-Single Chain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Hemophilia A in France, Germany, and Italy

    Dec 1, 2025, 00:00

  • CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)

    Dec 1, 2025, 00:00

  • PCR43 Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers

    Dec 1, 2025, 00:00

  • EE111 Budget Impact of Nivolumab Plus Ipilimumab Plus Chemotherapy as First-Line Treatment for Patients With Metastatic Non-Small Cell Lung Cancer in Switzerland

    Dec 1, 2025, 00:00

  • HPR127 International Reference Pricing (IRP) Analysis for Generic Medicines in Türkiye in 2024

    Dec 1, 2025, 00:00

  • EE248 Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations

    Dec 1, 2025, 00:00

  • EPH98 Examination of Attitudes Towards Vaccinations Among the Hungarian Population

    Dec 1, 2025, 00:00

  • HTA91 Correlation of Intermediate Clinical Endpoints (ICES) For Overall Survival (OS) In Localized or Locally Advanced Prostate Cancer (LPC/LAPC): Analysis of Individual Real-World Data (RWD)

    Dec 1, 2025, 00:00

  • SA62 Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies

    Dec 1, 2025, 00:00

  • PCR211 Review of Patient Decision Aids for Psoriasis

    Dec 1, 2025, 00:00

  • HPR222 Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-offs

    Dec 1, 2025, 00:00

  • APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety

    Dec 1, 2025, 00:00

  • HSD66 Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review

    Dec 1, 2025, 00:00

  • CO172 Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study

    Dec 1, 2025, 00:00

  • EPH173 Opportunity Gain in Resources as New Framework to Counterpart Burnout in Healthcare Systems

    Dec 1, 2025, 00:00

  • EE657 Societal and Economic Burden of Obesity in Bulgaria

    Dec 1, 2025, 00:00

  • RWD58 Detection of a Novel Safety Signal for Atorvastatin Potential Association With Hilar Lymphadenopathy Using FAERS Disproportionality Analysis and Molecular Docking

    Dec 1, 2025, 00:00

  • EE343 Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation

    Dec 1, 2025, 00:00

  • HTA70 Challenges in Defining Target Populations: An Analysis of Orphan Drug Health Technology Assessments in Germany 2024

    Dec 1, 2025, 00:00

  • HSD105 Subcutaneous vs. Intravenous Administration in Oncology: A Literature Review of Impacts on Patients, Providers, and Hospitals

    Dec 1, 2025, 00:00

  • SA106 Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenza/Influenza-Like Illness: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE190 Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)

    Dec 1, 2025, 00:00

  • HSD57 Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo

    Dec 1, 2025, 00:00

  • MSR98 Evaluating Treatment Benefit and Tolerability Based on Responder and Time-to-Event Analysis of Patient-Reported Outcomes in Cancer Clinical Trials: A Scoping Review

    Dec 1, 2025, 00:00

  • EE441 Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE114 Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Spain

    Dec 1, 2025, 00:00

  • MSR102 Exploring Artificial Intelligence's (AI's) Role in Literature Screening: A Comparative Analysis Paving the Way for More Efficient Evidence Synthesis

    Dec 1, 2025, 00:00

  • HTA21 Adapting HTA Frameworks for Precision Medicine: Methodological Advances in the UK and EU4

    Dec 1, 2025, 00:00

  • CO37 Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review

    Dec 1, 2025, 00:00

  • HPR72 EU HTA, Joint Clinical Assessment, and JCA Report: What Is the Possible Impact on Price Negotiation for Orphan Drugs in Germany?

    Dec 1, 2025, 00:00

  • P3 Zoom In: Uncovering Clinical Nuance in Simplified Health Economic Model Structure Through Artificial Intelligence

    Dec 1, 2025, 00:00

  • HTA128 EU HTA JCA PICO Consolidation Process Examples: Key Trends and Remaining Uncertainties

    Dec 1, 2025, 00:00

  • Award Winners

    Dec 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Peripheral Neuropathy Screening in Malaysian Adults With Thalassemia: An Integrated Modeling Approach

    Dec 1, 2025, 00:00

  • RWD73 Economic Burden of Type 1 Diabetes Mellitus After Disease Onset: A Claims Data Analysis

    Dec 1, 2025, 00:00

  • HPR11 Accelerating RTOR in Oncology: The AIM Model for Agile Trial Operations

    Dec 1, 2025, 00:00

  • EE596 Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal

    Dec 1, 2025, 00:00

  • HTA340 Transportability of Overall Survival in Multiple Myeloma From the US to Germany: A Benchmarking Study

    Dec 1, 2025, 00:00

  • EE117 Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals

    Dec 1, 2025, 00:00

  • EE280 Cost-Effectiveness of TEVAR With Active Control in Patients With TAA and TBAD: A Japanese Public Healthcare Payer Perspective

    Dec 1, 2025, 00:00

  • HTA324 The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling

    Dec 1, 2025, 00:00

  • EE525 Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial

    Dec 1, 2025, 00:00

  • PCR253 Understanding Patient Priorities in Psoriasis Treatment: A Review of Key Decision-Making Drivers

    Dec 1, 2025, 00:00

  • PCR202 Quality of Life in Patients With Severe Hemophilia A With Inhibitors Treated With Emicizumab in Mexico

    Dec 1, 2025, 00:00

  • PCR25 Assessment of Dermatology Life Quality Index Relevant (DLQI-R) in Psoriasis: A Practical Tool for Measuring Quality of Life in Elderly Populations

    Dec 1, 2025, 00:00

  • EE323 Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada

    Dec 1, 2025, 00:00

  • EE447 Evaluating the Societal and Economic Impact of Immunotherapy for Melanoma Treatment in Bulgaria

    Dec 1, 2025, 00:00

  • HTA364 What Has Worked Well in Fabry Disease? An HTA Landscape Assessment Study

    Dec 1, 2025, 00:00

  • HSD71 Mapping the Burden of Seizure Emergencies in Spain: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EPH263 Trends in Hospitalizations and Amputations in Diabetic Foot Ulcers (DFUs) in Germany 2019 to 2024

    Dec 1, 2025, 00:00

  • CO97 Enterocutaneous Fistula (ECF) and Economic Burden Preliminary Data From a HEOR Model of a Laboratory (LAB) Experiment Plus Potential Cost Avoidance

    Dec 1, 2025, 00:00

  • EE319 Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA

    Dec 1, 2025, 00:00

  • HSD21 Care Pathways Before and After Initial Diagnosis and Geographical Disparities Among Patients With Obstructive Hypertrophic Cardiomyopathy in Fran A Retrospective Claims Analysis

    Dec 1, 2025, 00:00

  • CO138 Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium

    Dec 1, 2025, 00:00

  • EE411 Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany

    Dec 1, 2025, 00:00

  • SA104 When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glauc ...

    Dec 1, 2025, 00:00

  • HSD24 Clinical Characteristics Among Patients Screening for Hepatitis C Virus (HCV) and HCV Positivity Rates, 2020-2024: Analysis of US Real-World Data

    Dec 1, 2025, 00:00

  • RWD52 Data-Driven Alerts to Support the Care of People Living With Epilepsy and Provide an Infrastructure for the Development of Real-World Evidence

    Dec 1, 2025, 00:00

  • HPR204 The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals

    Dec 1, 2025, 00:00

  • SA54 Indirect Comparison of Tarlatamab vs. Chemotherapy (CTx) in Patients With Previously Treated, Platinum-Refractory, or Resistant Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Dec 1, 2025, 00:00

  • EE281 Costing Analysis for the Management of Localized Renal Cell Carcinoma From the UK NHS Perspective

    Dec 1, 2025, 00:00

  • HSD101 Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Dec 1, 2025, 00:00

  • EPH36 Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan

    Dec 1, 2025, 00:00

  • CO131 Health-Related Quality of Life (HRQoL) in Duchenne Muscular Dystrophy (DMD): Insights From the DMD-QoL Instrument in the United States (US)

    Dec 1, 2025, 00:00

  • HPR52 Current Status of Home-Healthcare Pilot Programs in South Korea and Policy Discussions for Institutionalization

    Dec 1, 2025, 00:00

  • CO142 Impact of Tafamidis Use in Colombian Patients Diagnosed With ATTR-CM on Health-Related Quality of Life During One Year of Follow-up: Real-World Study in Colombia

    Dec 1, 2025, 00:00

  • HTA211 Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal

    Dec 1, 2025, 00:00

  • EPH37 Cardiovascular Implications of Loneliness and Social Isolation: Evidence From a Systematic Review

    Dec 1, 2025, 00:00

  • EPH262 Trends in Hospital Treatment of Follicular Lymphoma in Germany

    Dec 1, 2025, 00:00

  • EE71 Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program

    Dec 1, 2025, 00:00

  • EPH175 Patient-Relevant Benefits From Ixekizumab Treatment in Patients With Psoriasis: Data From the German National Psoriasis Registry PsoBest

    Dec 1, 2025, 00:00

  • HTA206 Integrating Patient Perspectives in HTA: What Can We Learn to Inform HTA-Focused Value Communications?

    Dec 1, 2025, 00:00

  • HTA370 Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform

    Dec 1, 2025, 00:00

  • CO185 Preliminary Real-World Comparative Analysis of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in Second-Line HER2-Positive Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • EE208 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective

    Dec 1, 2025, 00:00

  • EE505 Healthcare Resource Use and Direct Healthcare Costs Associated With Respiratory Syncytial Virus Infections in Individuals Aged 18 Years or Older in Italy: A Retrospective Observational Study

    Dec 1, 2025, 00:00

  • EPH178 Pertussis Vaccination and Test Rates in Germany by Asthma-COPD Comorbidity Status: A Healthcare Claims Data Analysis in Germany

    Dec 1, 2025, 00:00

  • MSR222 What Prompt Engineering Missed and How Context Engineering Fixes It

    Dec 1, 2025, 00:00

  • HPR93 Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy

    Dec 1, 2025, 00:00

  • HTA37 Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in Fran A Use Case in Rare Diseases

    Dec 1, 2025, 00:00

  • CO109 Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • MSR91 Evaluating Bayesian Borrowing Methods for Treatment Effect Extrapolation: A Simulation-Based Study

    Dec 1, 2025, 00:00

  • CO205 Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE593 Multistakeholder Survey on Communication of Uncertainties in Cost-Effectiveness Analysis by the Institute of Clinical and Economic Review

    Dec 1, 2025, 00:00

  • EE238 Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes

    Dec 1, 2025, 00:00

  • EPH249 The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis

    Dec 1, 2025, 00:00

  • HSD83 Patterns Of Adoption And Diffusion Of Biological Therapies In Inflammatory Bowel Disease: Patient-Centric Insights From Israel

    Dec 1, 2025, 00:00

  • RWD9 Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients: Results From a Real-World Study in the United States and Germany

    Dec 1, 2025, 00:00

  • CO15 Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©

    Dec 1, 2025, 00:00

  • HTA11 A NICE Idea? Assessing the Impact of the Severity Modifier in Oncology and Nononcology Single Technology Appraisals

    Dec 1, 2025, 00:00

  • EPH254 The Role of Body Fat in the Regulation of Male Fertility

    Dec 1, 2025, 00:00

  • MSR150 Modeling Physician Prescribing Decisions Based on Patient Characteristics for Positioning of a Novel Treatment Entering a Well-Established Category

    Dec 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »